<DOC>
	<DOC>NCT01615965</DOC>
	<brief_summary>The purpose of this study is to set up a model for detecting micrometastases in Lymph nodes of patients with prostate cancer by quantitative polymerase chain reaction and its impact on progression-free survival.</brief_summary>
	<brief_title>Detection of Micrometastases in Lymph Nodes of Patients With Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Neoplasm Micrometastasis</mesh_term>
	<criteria>Histologically confirmed prostate cancer Locally operable tumor Negative bone scan (obligatory if Gleason Score &gt; 7 or PSA &gt; 20ng/ml Karnofsky â‰¥ 80% Age 18 75 years Informed consent in written form Sufficient hematologic, coagulatory and renal function Compliant patient and geographic precondition for adequate followup given Manifest secondary tumor Organ metastases on CTscan /MRI or in Histology Myocardial infarction or stroke within the last 6 months Severe cardiovascular (Grade III IV according to NYHA), pulmonary (pO2 &lt; 60 mmHg), renal, hepatic oder hematopoetic impairment Severe active or chronic infection (z.B. pos. HIVAntibodyTest, HBsAgdetected in Serum and/ or chronic Hepatitis) Severe psychiatric disease Previous chemotherapy Previous pelvine radiotherapy</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>prostate cancer</keyword>
	<keyword>lymph node</keyword>
	<keyword>micrometastasis</keyword>
</DOC>